Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: A multi-institutional cohort study in Taiwan.

MLA

Su, Yu-Chen, et al. “Risk of Diabetic Macular Oedema with Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes Patients: A Multi-Institutional Cohort Study in Taiwan.” Diabetes, Obesity & Metabolism, vol. 23, no. 9, Sept. 2021, pp. 2067–76. EBSCOhost, https://doi.org/10.1111/dom.14445.

APA

Su, Y.-C., Shao, S.-C., Lai, E. C.-C., Lee, C.-N., Hung, M.-J., Lai, C.-C., Hsu, S.-M., & Hung, J.-H. (2021). Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: A multi-institutional cohort study in Taiwan. Diabetes, Obesity & Metabolism, 23(9), 2067–2076. https://doi.org/10.1111/dom.14445

Chicago

Su, Yu-Chen, Shih-Chieh Shao, Edward Chia-Cheng Lai, Chaw-Ning Lee, Ming-Jui Hung, Chi-Chun Lai, Sheng-Min Hsu, and Jia-Horung Hung. 2021. “Risk of Diabetic Macular Oedema with Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes Patients: A Multi-Institutional Cohort Study in Taiwan.” Diabetes, Obesity & Metabolism 23 (9): 2067–76. doi:10.1111/dom.14445.